Macintosh Versus Macgrath for Laryngoscopy in COVID 19 Hypoxemic ICU Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04956913

Enrollment

Registered

2021-07-09

Start date

2021-08-01

Completion date

2022-01-31

Last updated

2021-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Acute Respiratory Distress Syndrome

Keywords

Tracheal intubation, mechanical ventilation

Brief summary

In this comparative prospective study, we aim to compare the classic Macintosh laryngoscope and the Mac Grath videolaryncoscope in ICU covid 19 patients recruiting intubation and invasive mechanical ventilation. patients meeting inclusion criteria were randomized in 2 groups: MacGrath and Macintosh. we collected anthropometric and intubation data among all patients, and the 2 groups were compared regarding the time for intubation, the need of alternative techniques to intubate and the impact on the oxygenation by recording the lowest SPO2.

Detailed description

In this comparative prospective study, we aim to compare the classic Macintosh laryngoscope and the Mac Grath videolaryncoscope in ICU covid 19 patients recruiting intubation and invasive mechanical ventilation. All hypoxemic COVID19 patients requiring intubation were enrolled in this trial. all patients had a preoxygenation with non invasive ventilation with 100% oxygen. patients meeting inclusion criteria were randomized in 2 groups: MacGrath and Macintosh. we collected anthropometric and intubation data among all patients, and the 2 groups were compared regarding the time for intubation, the need of alternative techniques to intubate and the impact on the oxygenation by recording the lowest SPO2.

Interventions

DEVICEMac Grath

Patients of this group were intubated using Mac Gath videolaryngoscope

DEVICEMacintosh

Patients of this group were intubated using the Macintosh Laryngoscope

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All COVID 19 hypoxemic patients requiring tracheal intubation

Exclusion criteria

* hypoxemic cardiac arrest before intubation

Design outcomes

Primary

Measure	Time frame	Description
Time for tracheal intubation	10 minutes	Time from the blade pass the lips until the first breath was administred

Contacts

Primary ContactMhamed Mebazaa, Professor

msmebazaa@gmail.com0021622252589

Backup ContactAsma Ben Souissi, asso prof

bsouissiasma@gmail.com0021698336883

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026